R&D Center Inauguration Ceremony

On the morning of May 8, 2025, the inauguration ceremony of Titan Pharmaceuticals Co., Ltd. (Guangdong )’s R&D Center was grandly held in an exuberant atmosphere. The event gathered over 60 distinguished guests, including government representatives, industry experts, university leaders, partners, and media delegates, collectively witnessing a pivotal milestone in Titan Pharmaceuticals’ advancement in pharmaceutical R&D. Through ceremonial proceedings, a lion dance eye-dotting ritual, ribbon-cutting, and facility tours, the event comprehensively showcased Titan’s unwavering commitment and robust capabilities in pharmaceutical innovation, bolstering Zijin County’s vision to establish itself as a talent and technology hub for the pharmaceutical industry in the Guangdong-Hong Kong-Macao Greater Bay Area.

Ceremony Commencement: Envisioning the Future

The ceremony opened with a promotional video highlighting Titan Pharmaceuticals’ journey and future vision since its inception. Upholding the philosophy of “Innovation-Driven Development, Technology-Intelligent Future,” the company has built a strong reputation in pharmaceutical R&D and manufacturing through exceptional quality and relentless progress.

Amid resounding applause, the ceremony formally commenced. This event was honored to host distinguished leaders and guests from various sectors, including: Comrade Huang Chunpeng, Secretary of Zijin County Party Committee; Comrade Meng Lixin, Deputy Director of Heyuan Market Regulation Bureau; Comrade Xiao Qicong, Standing Committee Member of Zijin County and Deputy County Head; Comrade Zhu Hailong, Party Secretary of Lantang Town; Mr. Huang Guohong, Deputy Director of Guangdong University of Technology (Heyuan) Collaborative Innovation Research Institute; Mr. Fang Yanxiong, Deputy Director of Guangdong University of Technology Jieyang Campus; Comrade Tian Dongshan, Party Secretary of the School of Pharmacy at Guangdong Food and Drug Vocational College; Ms. Zhang Yan, Vice Dean of the School of Pharmacy at Guangdong Pharmaceutical University; President Jiang Yongnan of Guangzhou Songtian College; Mr. Dai Baiyang, Principal of Heyuan Health School; and over 60 representatives from government, academia, enterprises, and media. On behalf of Titan Pharmaceuticals Co., Ltd. (Guangdong ), the host extended the warmest welcome and most sincere gratitude to all attending guests.

Leadership Address: Government-Enterprise Collaboration Charts Development Blueprint

The leadership speeches then elevated the ceremony to a new crescendo. Mr. Wang Bao, Deputy General Manager of Titan Pharmaceuticals Co., Ltd. (Guangdong ) and Director of the R&D Center, delivered the opening address. He reflected on the company’s illustrious journey and future vision, emphasizing Titan’s strategic collaborations with global pharmaceutical leaders such as Sandoz and Hikma to establish a "Northern Hub for Pharmaceutical Innovation in the Greater Bay Area" through focused R&D on high-end cephalosporin generics. Leveraging proprietary technologies like the Waxetil taste-masking agent, the company will accelerate international production capacity expansion, deepen industry-academia-research partnerships, and drive sustained transformation of patented technologies. Mr. Wang further pledged increased R&D investment to attract top-tier talent and enhance independent innovation capabilities, committed to developing safer, more effective medicines that benefit patients and advance China’s pharmaceutical industry.

Followed by Comrade Xiao Qicong, Standing Committee Member and Deputy County Head of Zijin County, who delivered an address. He extended warm congratulations on the inauguration of Titan Pharmaceuticals Co., Ltd. (Guangdong )’s R&D Center and fully affirmed the company’s proactive contributions to local economic growth, employment promotion, and pharmaceutical industry advancement over the years. Comrade Xiao emphasized that as a pivotal enterprise in the regional pharmaceutical sector, the R&D Center’s completion would significantly enhance the company’s core competitiveness, serving as an exemplary model to drive the transformation and upgrading of Zijin County and Heyuan City’s pharmaceutical industry. The government, he stated, would continue supporting the company’s development, fostering an improved business environment to propel its innovation-driven journey.

Tradition Meets Innovation: Ribbon-Cutting Ceremony Reaches Climax

Following the inspiring speeches, the ribbon-cutting ceremony commenced as the event’s pinnacle moment. At the host’s invitation, ten distinguished guests took the stage guided by protocol officers. As they raised golden scissors amidst the crowd’s countdown—"5, 4, 3, 2, 1!"—the ribbon was cut in unison, igniting resounding cheers and applause. This symbolic act marked the official launch of Titan Pharmaceuticals’ R&D Center and heralded a new chapter in the company’s pharmaceutical innovation endeavors.

Following the ribbon-cutting ceremony, the culturally symbolic eye-dotting ritual commenced. In Chinese tradition, dotting the eyes of the auspicious lion imparts life and vitality, signifying the R&D Center's thriving development and auspicious fortune. As the ritual concluded, an exuberant lion dance performance infused the venue with jubilance, embodying the company’s high hopes and steadfast confidence in its future trajectory.

Finally, under the gaze of all attendees, the ceremony reached its historic pinnacle with the official unveiling of the R&D Center. Comrade Huang Chunpeng, Secretary of Zijin County Party Committee, and Mr. Deng Jiangyuan, General Manager of Titan Pharmaceuticals Co., Ltd. (Guangdong ), jointly revealed the center’s plaque. As the red drapery descended, unveiling the inscription "R&D Center," the venue erupted in renewed applause. Leaders and guests then gathered before the plaque for a commemorative group portrait, capturing this milestone moment.

The inauguration ceremony concluded successfully. Guided by protocol officers, all distinguished attendees assembled for a formal group photograph at the stage, preserving this invaluable collective memory of the occasion.

In-Depth Tour: Witnessing Core Strengths

Following the ceremony, guests were invited to tour the R&D center, experiencing firsthand the company’s advanced facilities and innovative achievements in pharmaceutical research. Deputy General Manager Wang Bao comprehensively introduced functional zones for integrated sample processing, synthetic experiments, and instrumental analysis. The center is equipped with cutting-edge instruments including UV/IR spectrophotometers, HPLC-MS systems, and inductively coupled plasma mass spectrometers (ICP-MS), enabling end-to-end drug development processes and providing robust technical support for pharmaceutical innovation.

Building on Achievement: Charting a New Blueprint

The inauguration of Titan Pharmaceuticals’ R&D Center marks a pivotal milestone in the company’s innovation-driven development strategy and signifies a new chapter in its pharmaceutical research journey. Bolstered by government support, academic collaborations, and partnerships, the company will leverage this center to enhance its innovation capacity and core competitiveness. Committed to breakthroughs in pharmaceutical R&D, Titan Pharmaceuticals aims to drive China’s medical industry forward and advance public health, writing an even more illustrious future.